L2 - Oral Dosing and Absorption Concepts Flashcards

1
Q

What are the three consecutive processes that govern drug absorption following oral administration?

A
  1. Disintegration and dissolution - release of active drug ingredients from the dosage form.
  2. Passive diffusion and mediated transport - translocation of dissolved drug across the GI mucosal barriers.
  3. First-pass metabolism in the GI mucosa and liver.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the factors determining the release and absorption kinetics of a drug following oral administration of solid dosage form?

A
  1. Release characteristics of dosage form
    - disintegration/deaggregation
    - dissolution of drug from granules
  2. Physicochemical properties of drug
    - ionisation (acid/base)
    - partition coefficient (octanol/water)
    - solubility in water
  3. Physiology of Gastrointestinal Tract
    - colonic retention
    - gastric emptying
    - intestinal motility
    - perfusion of the gastrointestinal tract
    - permeability of gut wall
  4. GI tract abnormalities
    - Crohn’s disease
    - Gastric resection (e.g. in obesity)
    - Diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens when dissolution&raquo_space; absorption?

A

permeability rate-limits absorption
e.g. sucralfate (Rx gastric and intestinal ulcers)
less common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens when dissolution &laquo_space;absorption?

A

dissolution rate-limits absorption.
changes in dissolution profoundly affect rate and sometimes extent of absorption.
more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Fick’s first law of diffusion and the formula for it?

A

Describes passive diffusion from a site of high concentration to a site of low concentration.
dQ/dt = P.A.(C(GI) - C(P))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some physiochemical factors that affect the permeability of the drug molecule?

A
  • size of the molecules (the larger the MW, the more difficult it is to pass through the membranes via paracellular transport).
    » Once a molecule exceeds MW350, it fails to cross the GI membrane via paracellular transport.
  • lipophilicity of the drug molecules. The more lipophilic the drug molecules, the greater its permeability.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which drug molecules fail to cross the GI membrane via paracellular transport and why?

A

oxytocin and calcitonin, MW exceeds 350 g/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some limitations of drug molecules as they become more lipophilic?

A
  • they have poorer aqueous solubility

- they have greater propensity to bind to membrane transporters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acidic drugs are unionised to a greater degree in the low pH environment of the stomach compared to the relatively higher pH environment of the small intestines. Hence there is a greater extent of absorption of acidic drugs in the stomach when they are dosed orally.

A

Disagree. Ceteris paribus, according to pH partition hypothesis, since a larger proportion of unionised acidic drugs exist in the stomach, the drug should be better absorbed in the stomach.

However, drug is better absorbed in small intestine because there are other extrinsic factors to consider-
it has a larger surface area of 200 square meters, higher blood flow of 1L/min, meets the sink condition and the intestinal epithelial cells have a more permeable membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can you say about the relationship of gastric emptying and speed of drug absorption?

A

The rate of gastric emptying becomes controlling step in the speed of drug absorption, as a result of absorption of all drugs being faster in the intestine than it is in the stomach.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does GI motility affect drug absorption?

A
  1. Gastric emptying - can control the rate at which the drug is presented to the major site of absorption, that is, the upper small intestine.
  2. Intestinal motility - determines the residence time of the dosage form in the small intestine, hence, changes in motility could alter drug bioavailability depending on whether dissolution or permeability is the rate-limiting step.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens to intestinal motility when dissolution is rate-limiting?

A

it will slow down, and allow for more complete dissolution and improved bioavailability (extent). Conversely, acceleration in motility can further limit dissolution and bioavailability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens to intestinal motility when permeability is rate-limiting?

A

Slowed motility allows for more time for absorption, thereby compensating for poor permeability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some factors that affect GI motility?

A
  1. Meal –> a heavier stomach results in a reduction in gastric emptying rate (decrease in GER)
  2. Physical state of gastric content –> solutions or suspensions of particles empty more rapidly than chunks of materials which need to be broken down before emptying.
  3. Concomitant administration of drugs:
    - anticholinergic, narcotic analgesics –> decreased gastric emptying rate.
    - metoclopramide –> increased gastric emptying rate.

Pregnancy also affects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some takeaways from the gastric emptying and intestinal transit graph?

A
  1. Small, non-disintegrating tablets tend to have better absorption, therefore lower transit time in the small intestine than large, non-disintegrating ones.
  2. The more food you consume, the longer the transit time in the stomach.
  3. Food does not affect the transit time in the small intestine, the small intestine will digest most of the food in 3-4 hours tops.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some takeaways from the case study of the GI absorption of acetaminophen with the co-administration of remifentanil, and the body position that it is administered in?

A
  • GI absorption of acetaminophen is affected by co-administration of remifentanil and body position?
  • Main site of absorption is small intestine. Body position affects gastric emptying rate.
  • When rate of drug absorption is faster, Tmax is shorter and Cmax is higher.
  • Require AUC to conclude the extent of absorption in the small intestine.
17
Q

What are some properties that vary in the GIT?

A
  1. surface area per unit length
  2. electrical resistance
  3. metabolic enzymes and transporters
  4. anaerobic microbes
  5. pH
  6. mean transit time
18
Q

How does surface area per unit length vary across the GIT?

A

decreases from duodenum to rectum

19
Q

How does electrical resistance (tightness of junction) vary across the GIT?

A

higher in colon than small intestine

20
Q

How do metabolic enzymes and transporters vary along the GIT?

A

They are distributed variably throughout the GIT.
Transporter expression differs between apical (facing lumen) and basolateral (facing vilous blood), and can change along the length of the membrane.
P-glycoprotein efflux pump’s activity increases along the GIT.

21
Q

How do anaerobic microbes distribute themselves in GIT?

A

they are abundant in colon.

22
Q

How does pH vary in the GIT?

A

pH 6.6 (proximal small intestine) –> pH 7.5 (terminal ileum) –> pH 6.4 (caecum) –> pH 7.0 (descending colon)

23
Q

How does mean transit time differ along the GIT?

A

3-4hr (small intestine), 10-36hr (large bowel)

24
Q

What is the takeaway of the GI absorption of polar drugs with ranitidine as an example?

A
  1. A drug may be polar if it has low MW but still poor absorption.
  2. The primary site of absorption of the drug is determined based on where there is the largest drop in drug concentration, and not based on the length of time that it spends in the organ.
25
Q

How is CYP3A4 able to achieve significant intestinal first-pass effect?

A

As a result of residing at the apical side of the intestinal epithelium, the enzyme allows for coupling of efflux transport and metabolism that results in significant intestinal first-pass.

26
Q

What type of transporter is P-glycoprotein?

A

efflux

27
Q

How do you calculate the total bioavailability, F of the drug?

A

F = Ff . Fg. Fh

28
Q

How do you calculate the fraction of drug that is lost at each step?

A

1-Ff, 1-Fg or 1-Fh

29
Q

What are some examples of intestinal wall interactions?

A

Coupling effects luminal efflux transport and metabolism within intestinal cells.

30
Q

(T/F): drugs administered according to the i.m. route experience low impedance by porous capillary membrane, only on the condition that they are uncharged, unionised, and have a smaller molecular size.

A

False. Drugs administered by the im route have low impedance by porous capillary membrane regardless of the three attributes.

e.g. vancomycin (water soluble, ionised, polar base with large MW)

31
Q

Under what conditions does blood flow and rate of absorption get reduced?

A

vasoconstriction and shock

32
Q

Under what conditions does blood flow and rate of absorption increase?

A

heat, fever and exercise

33
Q

(T/F): absorption of drug in solution from muscle and subcutaneous tissue is perfusion rate-limited.

A

true